Avelas Biosciences Selected as a 2019 Showcase Company by MedTech Innovator
June 17, 2019
News
Avelas Biosciences Grows Management Team
March 4, 2019
Avelas Biosciences Presents Phase II, Period 1 Data in Poster Session at San Antonio Breast Cancer Symposium
December 4, 2018
Updates to Avelas Biosciences Management Team
October 22, 2018
Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference
September 26, 2018
Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
August 2, 2018
Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference
June 14, 2018
Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference
March 21, 2018
Avelas Biosciences to Present at Oppenheimer 28th Annual Healthcare Conference
March 13, 2018
Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery
January 4, 2018